Epigenomics and targeted therapy in cancer. - Wikidata - awgldk - TriplyDB

Epigenomics and targeted therapy in cancer.

Epigenomics and targeted therapy in cancer.

http://www.wikidata.org/entity/Q46117582

about

The synthetic antihyperlipidemic drug potassium piperate selectively kills breast cancer cells through inhibiting G1-S-phase transition and inducing apoptosis.

P2860

Q41471022-0D7280AC-E5D3-48C0-9CE0-C9F15C78992F

P2860

Epigenomics and targeted therapy in cancer.

http://www.wikidata.org/entity/Q46117582

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Epigenomics and targeted therapy in cancer.

@en

Epigenomics and targeted therapy in cancer.

@nl

type

label

Epigenomics and targeted therapy in cancer.

@en

Epigenomics and targeted therapy in cancer.

@nl

prefLabel

Epigenomics and targeted therapy in cancer.

@en

Epigenomics and targeted therapy in cancer.

@nl

P1433

Q46117582-91715615-D584-4A30-9C33-9E64A33E1E38

P1476

Q46117582-5822C827-CA08-4DAF-A493-0E5D84276996

P2093

Q46117582-2C020F39-E98F-410B-8FA2-0A3B5D44AF96

Q46117582-AC44F26F-7016-4B37-8191-CA68D6E238C0

P2860

Q46117582-0174276D-5574-4F99-B98B-830128B63F42

Q46117582-26BDD13B-1ED1-4D1B-988C-5C176F5B8DFD

Q46117582-30443132-5FA5-41C1-A491-3678030DCB34

Q46117582-304DF469-3A76-4BD5-B2F1-B8A5FFB1BCD2

Q46117582-3CF078EE-4DAA-4C1C-A059-5CDCD038BF6C

Q46117582-4A7429D2-2AFC-436B-83B0-4E7D2217E39D

Q46117582-4A982E25-747A-444B-B914-62F668BB585C

Q46117582-4FD28344-FF76-47FC-84DA-78C819C918E8

Q46117582-506F6BC9-0B87-4B97-97F1-8386BC13D4F3

Q46117582-54E0E72E-3078-4F48-B16B-425CAD7FC25F

P304

Q46117582-BF3493FD-2FAD-4B9C-984A-85DAC0AD8C53

P31

Q46117582-7AE08F2F-45B6-4B72-BB8A-870712EDD1EF

P356

Q46117582-8E55304B-AA4B-4353-B476-FED54A1CBD91

P433

Q46117582-792B1AE6-F40E-456A-99B5-EFA2482C32F5

P478

Q46117582-F46C7021-EE3F-4997-90B0-41B43F52F8B7

P577

Q46117582-6D512E61-B251-4D33-AE61-A05C0CCFE5FF

P698

Q46117582-9CC81559-3CD3-4ECD-B6AC-C3FBFD2AAE68

P356

P1433

P1476

Epigenomics and targeted therapy in cancer.

@en

P2093

Ali R Jazirehi

http://www.w3.org/2001/XMLSchema#string

Ramin Nazarian

http://www.w3.org/2001/XMLSchema#string

P2860

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

Dimerization of a viral SET protein endows its function

The fundamental role of epigenetic events in cancer

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

BET domain co-regulators in obesity, inflammation and cancer

A TALE nuclease architecture for efficient genome editing

Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification

Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains

Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.

Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.

P304

571-575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/EPI.14.72

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25531250

http://www.w3.org/2001/XMLSchema#string